The report claimed Grifols "artificially reduced leverage by consolidating earnings of units it doesn't control and has overstated profit." In addition, the report stated "[Grifols] manipulates reported debt & EBITDA to artificially reduce reported leverage to 6x which we believe is closer to 10x-13x." The report concluded if these estimates are correct, Grifols "will face notably higher financing costs. Consequently, we believe shares are uninvestable, likely zero." On this news, Grifols's American Depositary Receipts fell $2.43 per share, or 21.83%, to close at $8.70 per share on January 9, 2024. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel.